Improving Access to HbA1c in Sub Saharan Africa

• Register: ClinicalTrials.gov
• Last refreshed on: 25 April 2016
• Main ID: NCT01460095
• Date of registration: 23/10/2011
• Prospective Registration: No
• Primary sponsor: Yaounde Central Hospital
• Public title: Improving Access to HbA1c in Sub Saharan Africa IA3
• Scientific title: Improving Access to HbA1c Measurement in Sub-Saharan Africa
• Date of first enrolment: March 2009
• Target sample size: 1349
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT01460095
• Study type: Interventional
• Study design: Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label
• Phase: N/A

Countries of recruitment

Cameroon, Guinea

Contacts

• Name: Eugene Sobngwi, MD, PhD
• Affiliation: Newcastle University, UK and Yaounde Central Hospital, Cameroon

Key inclusion & exclusion criteria

Inclusion Criteria:

- Confirmed diabetes mellitus irrespective of type

- Patients who have been followed regularly for at least one year prior to inclusion in
the target health facilities

- Adult age (18 years and over)

Exclusion Criteria:

- Individuals planning to migrate from study sites within one year

- Any intercurrent acute illness

- Enrollment in any other concomitant intervention study



Age minimum: 18 Years
Age maximum: N/A
Gender: Both

Health Condition(s) or Problem(s) studied

Diabetes Mellitus

Intervention(s)

Other: HbA1c measurement and education

Primary Outcome(s)

one year change in glycated haemoglobin (HbA1c) [Time Frame: Baseline and 12 months]

Secondary Outcome(s)

One-year change in urinary albumin excretion [Time Frame: Baseline and 12 months]

One-year change in proportion of patients reaching HbA1c targets [Time Frame: Baseline and 12 months]

Secondary ID(s)

LT07-135

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Newcastle University

University of Yaounde 1